ScoreWhy is Champions Oncology, Inc. ?
1
The company has declared Positive results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Highest at USD 7.39 MM
- NET PROFIT(HY) Higher at USD 2.66 MM
- ROCE(HY) Highest at 503.05%
2
With ROE of 117.52%, it has a attractive valuation with a 17.42 Price to Book Value
- Over the past year, while the stock has generated a return of 55.50%, its profits have risen by 172.1% ; the PEG ratio of the company is 0.1
3
Market Beating Performance
- The stock has generated a return of 55.50% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Champions Oncology, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Champions Oncology, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Champions Oncology, Inc.
41.2%
0.52
75.89%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
12.13%
EBIT Growth (5y)
39.59%
EBIT to Interest (avg)
-1.09
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
5.60
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
43.87%
ROCE (avg)
40.85%
ROE (avg)
24.39%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
17.42
EV to EBIT
13.93
EV to EBITDA
10.75
EV to Capital Employed
24.29
EV to Sales
1.60
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
174.42%
ROE (Latest)
117.52%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend15What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD 7.39 MM
NET PROFIT(HY)
Higher at USD 2.66 MM
ROCE(HY)
Highest at 503.05%
-16What is not working for the Company
RAW MATERIAL COST(Y)
Grown by 21.73% (YoY
DEBTORS TURNOVER RATIO(HY)
Lowest at 5.49 times
NET SALES(Q)
Lowest at USD 12.36 MM
OPERATING PROFIT(Q)
Lowest at USD -1.32 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -10.68 %
PRE-TAX PROFIT(Q)
Lowest at USD -1.96 MM
NET PROFIT(Q)
Lowest at USD -1.83 MM
EPS(Q)
Lowest at USD -0.13
Here's what is working for Champions Oncology, Inc.
Operating Cash Flow
Highest at USD 7.39 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Here's what is not working for Champions Oncology, Inc.
Pre-Tax Profit
At USD -1.96 MM has Fallen at -222.75%
over average net sales of the previous four periods of USD 1.6 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -1.83 MM has Fallen at -214.21%
over average net sales of the previous four periods of USD 1.61 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Net Sales
At USD 12.36 MM has Fallen at -15.65%
over average net sales of the previous four periods of USD 14.65 MMMOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Net Sales
Lowest at USD 12.36 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit
Lowest at USD -1.32 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (USD MM)
Operating Profit Margin
Lowest at -10.68 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at USD -1.96 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (USD MM)
Net Profit
Lowest at USD -1.83 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
EPS
Lowest at USD -0.13
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Lowest at 5.49 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
Raw Material Cost
Grown by 21.73% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
